Minmin Wang

Title: Minmin Wang: Innovator in Pharmaceutical Chemistry

Introduction

Minmin Wang is a prominent inventor based in Fishers, IN (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various physiological disorders. Her work is characterized by a strong focus on innovative solutions to complex health issues.

Latest Patents

Minmin Wang holds a patent for a compound titled "Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators." This invention provides a compound of the formula: Formula (I), or a pharmaceutically acceptable salt thereof. The patent outlines pharmaceutical compositions that comprise an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient. The methods described in the patent are aimed at treating physiological disorders, particularly congestive heart disease, hypertension, and atherosclerosis, by administering an effective amount of the compound to patients.

Career Highlights

Minmin Wang is currently employed at Eli Lilly and Company, where she continues to advance her research and development efforts. Her work at Eli Lilly has positioned her as a key player in the pharmaceutical industry, contributing to the development of innovative treatments that address critical health challenges.

Collaborations

Some of her notable coworkers include Konstantinos Gavardinas and Prabhakar Kondaji Jadhav. Their collaborative efforts have further enhanced the research environment at Eli Lilly, fostering innovation and the development of new therapeutic solutions.

Conclusion

Minmin Wang's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in addressing health issues. Her patent and ongoing work at Eli Lilly and Company highlight her commitment to improving patient outcomes through scientific advancement.